Katherine Block

Katherine Block

Company: Sangamo Therapeutics

Job title: Director, Biomarker Sciences


Translating Oncology Successes into Outside Disease Indications 11:30 am

How CDx approaches in oncology can be modified to enable development for Gene Therapy and Rare Diseases Pathways to develop a CDx for Gene Therapy Planning and timeline considerations when incorporating CDx into a clinical development plan Considerations in selecting CDx partners for gene therapy drug developmentRead more

day: Track C - Day 1 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.